SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001204459-11-002358
Filing Date
2011-08-22
Accepted
2011-08-22 16:17:21
Documents
11
Period of Report
2011-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 8839
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 38523
3 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 7398
4 EXHIBIT 10.3 exhibit10-3.htm EX-10.3 7406
5 EXHIBIT 10.4 exhibit10-4.htm EX-10.4 7323
6 EXHIBIT 10.5 exhibit10-5.htm EX-10.5 7349
7 EXHIBIT 10.6 exhibit10-6.htm EX-10.6 7392
8 EXHIBIT 10.7 exhibit10-7.htm EX-10.7 7358
9 EXHIBIT 10.8 exhibit10-8.htm EX-10.8 7351
10 EXHIBIT 10.9 exhibit10-9.htm EX-10.9 7296
11 EXHIBIT 10.10 exhibit10-10.htm EX-10.10 7279
  Complete submission text file 0001204459-11-002358.txt   114637
Mailing Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3
Business Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3 (905) 479-3245
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

IRS No.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-30813 | Film No.: 111050062
SIC: 2834 Pharmaceutical Preparations